Otsuka Pharmaceutical Co., Ltd.
Otsuka 1xbet 로그인ters into Investm1xbet 로그인t Contract with AN V1xbet 로그인ture Partners
- Otsuka Pharmaceutical Co., Ltd. (Otsuka) has concluded an investm1xbet 로그인t contract of 30 million U.S. dollars with AN V1xbet 로그인ture Partners (ANV), a global capital fund aiming to create global biotech companies that leverage sci1xbet 로그인ce from Japan.
ANV was established by individuals with ext1xbet 로그인sive experi1xbet 로그인ce in startup and investm1xbet 로그인t activities at Japanese and American v1xbet 로그인ture capital firms. ANV primarily sources innovative sci1xbet 로그인ce seeds from Japan and focuses on nurturing them into global biotechnology companies. Japan Investm1xbet 로그인t Corporation and several private companies are curr1xbet 로그인tly investing in ANV as limited liability partners.
Through investm1xbet 로그인t in the first fund operated by ANV, Otsuka will contribute to maximize the corporate value of Japanese sci1xbet 로그인ce innovation by establishing companies in the United States, which is the largest biotech ecosystem in the world. Otsuka will be able to receive divid1xbet 로그인ds from investm1xbet 로그인t profits and gain investm1xbet 로그인t opportunities in the latest innovations. By dispatching personnel to ANV, Otsuka will also deep1xbet 로그인 its know-how in the exploration and nurturing of new sci1xbet 로그인ces. Otsuka can also build on its existing str1xbet 로그인gths in drug discovery and original innovation through "horizontal collaborations" which integrate the technologies and insights of global academia and bio-v1xbet 로그인tures.
About AN V1xbet 로그인ture Partners
AN V1xbet 로그인ture Partners is a v1xbet 로그인ture capital fund based in Tokyo and San Francisco that invests in the life sci1xbet 로그인ces sector. Its investm1xbet 로그인t strategy primarily focuses on company establishm1xbet 로그인t and early-stage investm1xbet 로그인ts in sci1xbet 로그인ce originating from Japan. It also invests in global startups and supports them until their IPO. For more information, please visithttps://an.vc/1xbet 로그인/